Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CLPS (CLPS) Total Liabilities: 2019-2025

  • CLPS's Total Liabilities rose 31.26% to $60.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $60.5 million, marking a year-over-year increase of 31.26%. This contributed to the annual value of $60.5 million for FY2025, which is 31.26% up from last year.
  • CLPS's Total Liabilities amounted to $60.5 million in Q2 2025, which was up 31.26% from $46.1 million recorded in Q2 2024.
  • In the past 5 years, CLPS's Total Liabilities ranged from a high of $60.5 million in Q2 2025 and a low of $25.0 million during Q2 2021.
  • For the 3-year period, CLPS's Total Liabilities averaged around $45.5 million, with its median value being $46.1 million (2024).
  • As far as peak fluctuations go, CLPS's Total Liabilities fell by 12.53% in 2023, and later soared by 54.68% in 2024.
  • Over the past 5 years, CLPS's Total Liabilities (Quarterly) stood at $25.0 million in 2021, then skyrocketed by 36.33% to $34.1 million in 2022, then fell by 12.53% to $29.8 million in 2023, then surged by 54.68% to $46.1 million in 2024, then surged by 31.26% to $60.5 million in 2025.
  • Its Total Liabilities was $60.5 million in Q2 2025, compared to $46.1 million in Q2 2024 and $29.8 million in Q2 2023.